GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 151 - 175 of 4050 in total
Antibody Patient Onset (days) ▲ Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU)
IgG Patient 3 -180 mild
G09482NW
49
IgG Patient 3 -180 mild
G09609EN
44
IgG Patient 3 -180 mild
G10133VD
54
IgG Patient 3 -180 mild
G10789DJ
45
IgG Patient 3 -180 mild
G11460AB
832
IgG Patient 3 -180 mild
G12200GB
1857
IgG Patient 3 -180 mild
G14569AR
3411
IgG Patient 3 -180 mild
G14844CX
53
IgG Patient 3 -180 mild
G14988WV
48
IgG Patient 3 -180 mild
G15209MJ
44
IgG Patient 3 -180 mild
G15407YE
246
IgG Patient 3 -180 mild
G16579HJ
58
IgG Patient 3 -180 mild
G17140UR
73
IgG Patient 3 -180 mild
G17266GE
57
IgG Patient 3 -180 mild
G17390SF
50
IgG Patient 3 -180 mild
G17689EW
937
IgG Patient 3 -180 mild
G18057VI
54
IgG Patient 3 -180 mild
G19118WX
24795
IgG Patient 3 -180 mild
G19868AX
35
IgG Patient 3 -180 mild
G21290RB
57
IgG Patient 3 -180 mild
G21320TF
36
IgG Patient 3 -180 mild
G21460SG
46
IgG Patient 3 -180 mild
G21675ZL
83
IgG Patient 3 -180 mild
G22768VO
44
IgG Patient 3 -180 mild
G24432YB
48

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024